Cell-free DNA fragments shed into circulating blood may provide an important biomarker for monitoring the progression and treatment of glioblastoma, a highly aggressive brain cancer, according to a study by researchers at TGen, part of City of Hope, and the Mayo Clinic.
Jason Zhang, an assistant professor of bioengineering in the UCLA Samueli School of Engineering and a member of the UCLA Health Jonsson Comprehensive Cancer Center, has received an $800,000 grant from the V Foundation for Cancer Research to investigate how glioblastoma cells become resistant to targeted treatments.
